Tradewinds Capital Management LLC Sells 150 Shares of Monsanto Co. (MON)
Tradewinds Capital Management LLC reduced its stake in shares of Monsanto Co. (NYSE:MON) by 7.9% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 1,739 shares of the company’s stock after selling 150 shares during the period. Tradewinds Capital Management LLC’s holdings in Monsanto were worth $180,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Signaturefd LLC boosted its stake in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares in the last quarter. Enterprise Financial Services Corp boosted its stake in Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares in the last quarter. Bartlett & Co. LLC boosted its stake in Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock valued at $145,000 after buying an additional 134 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares in the last quarter. Finally, Palladium Partners LLC bought a new stake in Monsanto during the second quarter valued at approximately $205,000. 79.02% of the stock is owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded down 0.42% during mid-day trading on Friday, reaching $102.11. The company’s stock had a trading volume of 3,217,128 shares. Monsanto Co. has a 1-year low of $83.73 and a 1-year high of $114.26. The stock’s 50 day moving average price is $104.39 and its 200 day moving average price is $101.78. The stock has a market capitalization of $44.69 billion, a P/E ratio of 34.17 and a beta of 1.19.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The company earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. Monsanto’s revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.19) EPS. Analysts expect that Monsanto Co. will post $4.89 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.12%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
Several equities research analysts recently commented on the company. Goldman Sachs Group Inc. raised Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price target for the company in a report on Tuesday, September 27th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a report on Wednesday, June 29th. Piper Jaffray Cos. set a $128.00 price target on Monsanto and gave the company a “buy” rating in a report on Thursday, September 15th. Argus reaffirmed a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Sunday, October 9th. Finally, Citigroup Inc. reaffirmed a “neutral” rating and issued a $112.00 price target (up previously from $94.00) on shares of Monsanto in a report on Friday, July 1st. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $114.65.
In other Monsanto news, Director Charles S. Mcmillan purchased 3,500 shares of the business’s stock in a transaction on Monday, October 10th. The stock was bought at an average cost of $103.23 per share, for a total transaction of $361,305.00. Following the acquisition, the director now owns 64,009 shares of the company’s stock, valued at approximately $6,607,649.07. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert T. Fraley sold 80,631 shares of the business’s stock in a transaction on Friday, October 14th. The shares were sold at an average price of $102.04, for a total value of $8,227,587.24. Following the completion of the transaction, the executive vice president now owns 38,711 shares of the company’s stock, valued at $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is owned by company insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.